Tag: Bharat Biotech
Bharat Biotech said on Tuesday that its vaccine candidate, Covaxin, will be effective in dealing with new strains of coronavirus. ....
The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech's 'Covaxin' for emergency use in India. The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI). ....
The NITI Aayog has promulgated a price range of Rs 300-500 for two Covid vaccines that would be available for the priority group at private facilities in the third phase of vaccination set to begin from March 1, sources privy to the development told IANS, adding that the Bharat Biotech's Covaxin would cost a bit higher. ....
Prime Minister Narendra Modi on Tuesday gave a clarion call to all the BJP MPs and party workers to help eligible people in receiving Covid-19 vaccines as well as help them to reach vaccination centres. ....
Hyderabad-based pharma major Bharat Biotech's Covid vaccine Covaxin will be added to the UK government's approved list of vaccines for international travellers from November 22. ....
Leading vaccine maker Bharat Biotech on Monday announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV) and will begin its human trials next month. ....
EnvoEnvoys of 64 countries visit Covid vaccine makers in Hyderabadys of 64 countries on Wednesday visited the facilities of Bharat Biotech and Biological E, which are developing vaccines for coronavirus. ....
Congress leader Shashi Tharoor has criticised the government for giving the nod to Bharat Biotech's Covid vaccine without phase-3 trials.....
In a relief of sorts, from May 5, India has apparently halted the contentious doles and exports of vaccines which has erupted into a massive political furore across the country, as per an RTI reply released here on Monday. ....
FDA has asked Ocugen, the US partner of Bharat Bio, to launch an additional trial so that it can file for for a full approval ....